Document is current
Any future updates will be listed below
-
Authors
Kim, Hyewon
Yoo, Juhwan
Han, Kyungdo
Lee, Dong-Yun
Fava, Maurizio
Mischoulon, David
Jeon, Hong Jin
-
Funding
Funding for this research was provided by:
The Ministry of Science and ICT (S1601-20-1041)
The Ministry of Health & Welfare (HR21C0885)
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 29 May 2022
First Online: 16 June 2022
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Samsung Medical Center, and informed consent was not obtained from the subjects because the national claims data was used.
: Not applicable.
: Dr. Mischoulon has received research support from Nordic Naturals and heckel medizintechnik GmbH. He has received honoraria for speaking from the Massachusetts General Hospital Psychiatry Academy. He also works with the MGH Clinical Trials Network and Institute (CTNI), which has received research funding from multiple pharmaceutical companies and NIMH.
